Order Before 2pm for
Same Day Dispatch

Free delivery

On ALL UK Orders (No Minimum Spend!)

Free Gifts

With Every Order*

Worldwide shipping

From £3.99

Glucosamine Sulphate Tablets 2KCL 1500mg

Glucosamine Sulphate Tablets 2KCL 1500mg

(2 customer reviews)

Manufactured in the UK – Only 1 Tablet per Day Needed




What is Nuke Nutrition Glucosamine Sulphate Tablets?
Glucosamine is a large component of cartilage, which acts as a shock absorber in our joints. Cartilage can break down as we get old, hence stiff and painful joints. Nuke Nutrition’s 1500mg Glucosamine tablets provide 1500mg in each tablet.

Key Benefits:
– 1500mg per single tablet
– Easy to swallow
– 1 tablet per day

60 Tablets
Amount per Container: 60
Serving Size - 1 Tablets
Servings per Pack - 60

120 Tablets
Amount per Container: 120
Serving Size - 1 Tablet
Servings per Pack - 120

180 Tablet
Amount per Container: 180
Serving Size - 1 Tablet
Servings per Pack - 180
Active Ingredients per Serving (1 Tablet):
Glucosamine Sulphate 1500mg

Allergen Warning: This product contains Crustaceans.

Manufactured in the UK
Consume 1 tablet per day with your first meal of the day with a glass of water.

Do not exceed stated dose.
Not to be used as a substitute for a varied / balanced diet.
Store in a cool dry place and out of the reach of children.
This product is not suitable for vegetarians or vegans.

2 reviews for Glucosamine Sulphate Tablets 2KCL 1500mg

  1. Miss T

    great service, as expected from nuke x

  2. josh w

    I started taking Glucosamine Sulphate Tablets due to me getting really sore knees after squatting in the gym and I thought I would give them a go and to be honest I was not really expecting them to do a great deal as I have always struggled with my knees, since taking them I don’t get much if any knee pain after squats or leg day, meaning I can now get two leg days in one week as I don’t suffer with the knee pain anymore I would 100% try these if you suffer with sore joints or knees.

Add a review

Your email address will not be published.